Tempest Therapeutics Statistics
NASDAQ: TPSTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.7914+0.0039 (+0.50%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Tempest Therapeutics by the numbers
Tempest Therapeutics has a market capitalization of $13.4 million based on 16.89M shares outstanding. With trailing EPS of $-3.98, Tempest Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.3% below its 50-day average and 53.7% below its 200-day average.
Average daily trading volume is 2.63M shares, or about $2.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TPST valuation vs. peer median
| Metric | TPST | Peer median | Difference |
|---|---|---|---|
| Market cap | $13.37M | $13.67M | -2% |
| Avg. volume | 2.63M | 413.30K | +536% |
Peer median across 8 companies: LTRN, BFRG, CTXR, BFRI, LSTA, CLRB, HIND, BIVI.
Valuation
- Market cap
- $13.37M
- EPS (TTM)
- $-3.98
- Shares outstanding
- 16.89M
Price and trading
- Previous close
- 0.7875
- Open
- 0.79
- Day range
- 0.7515 – 0.8199
- 52-week range
- 0.743 – 12.23
- 52-week change
- -92.63%
- 50-day moving average
- 0.9569
- Beta
- —
- Volume
- 305.21K
- Average volume
- 2.63M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 13.37M
- Forward Pe
- -0.65
- Eps
- -3.98
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.23
- Week52 Low
- 0.74
- Avg Volume
- 2.63M
- Shares Outstanding
- 16.89M
- Ma50
- 0.96
- Ma200
- 1.71
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -93.53%
- Pct From52w Low
- 6.51%